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ABSTRACT
The α-chemokine stromal-derived factor 1 (SDF-1), which binds to the CXCR4
receptor, directs migration and homing of CXCR4+ hematopoietic stem/progenitor
cells (HSPCs) to bone marrow (BM) stem cell niches. Nevertheless, it is also known
that CXCR4−/− fetal liver-derived hematopoietic stem cells engraft into BM and that
blockade of CXCR4 by its antagonist AMD3100 does not prevent engraftment of HSPCs.
Because of this finding of SDF-1-CXCR4-independent BM homing, the unique role
of SDF-1 in HSPC homing has recently been challenged. While SDF-1 is the only
chemokine that chemoattracts HSPCs, other chemoattractants for these cells have
recently been described, including the bioactive phosphosphingolipid sphingosine-1phosphate (S1P). To address the potential role of S1P in homing of HSPCs to BM, we
performed hematopoietic transplants into mice deficient in BM-expressed sphingosine
kinase 1 (Sphk1−/−) using hematopoietic cells from normal control mice as well as
cells from mice in which floxed CXCR4 (CXCR4fl/fl) was conditionally deleted. We
observed the presence of a homing and engraftment defect in HSPCs of Sphk1−/− mice
that was particularly profound after transplantation of CXCR4−/− BM cells. Thus, our
results indicate that BM-microenvironment-expressed S1P plays a role in homing of
HSPCs. They also support the concept that, in addition to the SDF-1-CXCR4 axis, other
chemotactic axes are also involved in homing and engraftment of HSPCs.

Nevertheless, the role of the SDF-1-CXCR4 axis
in stem cell homing to BM has been recently challenged
by several observations that support the involvement of
SDF-1-CXCR4-independent homing mechanisms [7–9].
This evidence is based on observations that i) CXCR4−/−
fetal liver HSPCs home to BM in an SDF-1-independent
manner [7], ii) homing of murine HSPCs made refractory
to SDF-1 by incubation and co-injection with a CXCR4
receptor antagonist (AMD3100) is normal or only mildly
reduced [8], and iii) HSPCs in which CXCR4 has been
knocked down by means of an SDF-1 intrakine strategy
are still able to engraft [9]. It is also known that iv)
myeloablative conditioning for transplantation induces

INTRODUCTION
Stromal-derived factor 1 (SDF-1), which binds
to the seven-transmembrane-spanning GαI proteincoupled receptor CXCR4, is unique among the family
of chemokines, because it chemoattracts hematopoietic
stem/progenitor cells (HSPCs) [1–3]. Since the CXCR4
receptor is expressed on HSPCs, SDF-1 plays an
important role in regulating the trafficking of these cells
and facilitates their homing and engraftment in BM
after transplantation. Furthermore, SDF-1 is involved
in the subsequent retention of HSPCs in BM stem cell
niches [3–6].
www.impactjournals.com/oncotarget
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a highly proteolytic microenvironment in BM that leads
to proteolytic degradation of SDF-1 and thus severely
attenuates its chemotactic homing gradient [10].
Evidence has accumulated that one of the most
potent chemotactic factors for HSPCs is the bioactive
phosphosphingolipid sphingosine-1-phosphate (S1P)
[11]. An S1P gradient in PB also plays a crucial role in
mobilization of HSPCs from BM into PB [11–16]. The
level of S1P in BM is regulated by a balance in activity
between type 1 SP-1 kinase (Sphk1) and S1P lyase, which
degrades S1P. Interestingly, in the past we observed that
mice in which S1P lyase is inhibited by deoxypyridoxin
(DOP) display an impaired release of HSPCs from BM
to PB in response to mobilizing agents [11, 16]. This
suggested the involvement of S1P in retention of HSPCs in
BM. Based on this finding, we hypothesized that S1P plays
a role also in homing and engraftment of HSPCs to BM
and is involved in SDF-1-independent homing [10–12]
what has been subsequently supported by observation that
Sphk1-KO mice engraft poorly with WT BM cells exposed
to AMD3100 [16]. To address this issue more directly and
to shed more light on the role of BM-expressed S1P in
the homing process, we performed homing experiments
in Sphk1-deficient mice, transplanting these animals with
wild type (WT) or CXCR4−/− HSPCs [17].
We report here a defect in homing as well as
engraftment of WT and, in particular, CXCR4−/−HSPCs
in Sphk1−/− mice. Thus, our data indicate that BMmicroenvironment-expressed S1P plays a role in the
homing of HSPCs and supports the concept that other
chemotactic axes in addition to the SDF-1-CXCR4 axis
are involved in homing and engraftment of HSPCs.

transplanted BM cells isolated from green fluorescent
protein (GFP) mice into lethally irradiated normal
control or Sphk1−/− animals. Twenty-four hours after
transplantation, the mice were sacrificed, and we evaluated
the number of GFP+ cells in BM by FACS (Figure 2A)
and the number of clonogenic progenitors that lodged
during this time to BM, and we were able to grow in vitro
GFP+ colonies after isolation from the long bones (Figure
2B). We found that Sphk1−/− mice had significantly lower
numbers of GFP+ cells and GFP+ clonogeneic progenitors
in BM compared with normal control animals.

A defect in short-and long-term BM engraftment
of HSPCs in Sphk1−/− animals
The outcome of a hematopoietic transplant is a
function of homing/lodging efficiency and the number of
transplanted cells. To study the role of BM-expressed S1P
in the homing of HSPCs, we transplanted into Sphk1−/−mice
normal control BM cells as well as CXCR4fl/fl BM cells in
which expression of CXCR4 had been efficiently deleted
by Cre-recombinase [17]. Our preliminary results indicated
that the chemotactic responsiveness of normal control and
CXCR4−/− BM clonogenic progenitors to S1P gradients was
similar (Supplementary Figure S1).
Thus, we transplanted normal BM cells into normal
(control) mice or Sphk1−/− animals and evaluated the
number of day-11 CFU-GM colonies present in BM as
well as the number of day-11 spleen colonies formed
by CFU-S (Figure 3A) and found impaired homing of
HSPCs to BM in Sphk1−/− mice. Similar and even more
profound defects in the number of day-11 CFU-GM
colonies and day-11 CFU-S colonies were observed after
transplantation of CXCR4−/− BM cells (Figure 3B).
Based on these results, we transplanted normal BM
cells or CXCR4−/− BM cells into lethally irradiated normal
or Sphk1−/− mice and followed the recovery of white
blood cells and platelet counts in these animals (Figure
4A, 4B). We found that Sphk1−/−animals, compared with
WT mice, showed a defect in recovery of leucocytes and
platelets and that this defect was more pronounced if mice
were transplanted with CXCR4−/− BM cells. As shown in
Figure 4, the recovery of peripheral blood counts in Sphk1−/−
mice after transplantation of CXCR4−/− cells was delayed by
two weeks compared with normal mouse recipients.

RESULTS
Normal steady-state hematopoiesis in Sphk1−/− mice
Since Sphk1 is the main BM-expressed isoform of
Sphk, we became interested in the basic hematopoietic
parameters of animals that lack expression of this enzyme.
Figure 1A, 1B shows that Sphk1−/− animals, in comparison
with WT controls, display normal peripheral blood counts
in all three major hematopoietic lineages. Moreover, these
animals also have normal numbers of Sca-1+c-kit+Lin−
(SKL) cells enriched for HSPCs in BM (Figure 1C).
Furthermore, by employing in vitro clonogenic assays,
we found that BM cells isolated from Sphk1−/− mice grow
similar numbers of CFU-GM, BFU-E, and CFU-Meg
colonies as normal control mice (Figure 1D).

DISCUSSION
The salient observation of this study is that BMexpressed S1P is involved in homing and engraftment of
HSPCs to BM. Despite the fact that the SDF-1-CXCR4
axis is crucial for retention of HSPCs in BM niches and
that Sphk1−/− mice do not show any hematopoietic defects
under steady-state conditions, our results support the
involvement of S1P in this process and the existence of
an SDF-1-independent, S1P-mediated homing mechanism.

Defective homing of WT BM cells in Sphk1−/− mice
Homing or lodging of HSPCs to BM after transplan
tation precedes their engraftment and expansion in
the hematopoietic microenvironment [3–6]. To study
the homing process of HSPCs in Sphk1−/− animals, we
www.impactjournals.com/oncotarget
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Figure 1: Sphk1 deficiency does not affect hematological homeostasis. Bone marrows of WT and Sphk1−/− mice were isolated
and evaluated for peripheral blood white blood cell A. and red blood cell B. parameters as well as the number of SKL cells in BM C. and
in vitro clonogenic progenitor cells D. The data represent an average of at least six mice per experimental group.

Figure 2: A defect in homing of HSPCs from GFP+ mice in Sphk1−/− BM. Panel A. Lethally irradiated Sphk1−/− mice (six

mice per group) were transplanted with 5 × 106 GFP+ bone marrow mononuclear cells (BMMNCs); 24 hours after transplantation femoral
BMMNCs were harvested; the number of GFP+ cells in murine BM was evaluated by FACS (panel A); and the number of clonogenic
GFP+ CFU-GM progenitors was enumerated in an in vitro colony assay (panel B). No colonies were formed in lethally irradiated and nontransplanted mice (irradiation control). The data in panels A and B represent the combined results from two independent experiments (n =
10). *p < 0.005.
www.impactjournals.com/oncotarget
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Figure 3: A defect in short-term engraftment of WT and CXCR4−/− HSPCs in Sphk1−/− BM. Panel A. Lethally irradiated

mice (six mice per group) were transplanted with 1.5 × 105 bone marrow mononuclear cells (BMMNCs) from WT mice, and 11 days after
transplantation spleens were removed and femoral BMMNCs were harvested for counting the number of CFU-S colonies and plating to
count the number of CFU-GM colonies, respectively. Panel B. In similar experiments, mice were lethally irradiated and transplanted with
1.5 × 105 BMMNCs from CXCR4−/− mice. Eleven days after transplantation, spleens were removed and femoral BMMNCs were harvested
for counting the number of CFU-S colonies and plating to count the number of CFU-GM colonies, respectively. The data in panels A and
B represent the combined results from three independent experiments (n = 9). *p < 0.005.

Overall, the developmental and postnatal migration
of HSPCs is still not well understood. HSPCs migrate
during embryonal development, colonizing different
organs where hematopoiesis is initiated. In the second
trimester of gestation, they colonize fetal liver, which is
a major hematopoietic organ at this stage of development
[18–20]. Despite the fact that SDF-1 is considered to be
the most important factor regulating migration of HSPCs,
surprisingly, murine embryos with CXCR4 or SDF-1
knocked out have a normal number of myeloid HSPCs
in fetal liver [21–24]. Because fetal liver is colonized
by HSPCs migrating from the aorta-gonad-mesonephros
(AGM) region, this result suggests that this process is
mediated by chemoattractants other than SDF-1 [21–24].
www.impactjournals.com/oncotarget

Moreover, as mentioned in the introduction, HSPCs
isolated from CXCR4−/− murine fetal liver home to BM
in an SDF-1-independent manner [7], and it is also well
known that homing of murine HSPCs made refractory
to SDF-1 by incubation and co-injection with a CXCR4
receptor antagonist (AMD3100) is normal or only mildly
reduced [8]. Finally, as we demonstrate here, CXCR4−/−
BM cells generated by a Cre-recombinase strategy also
home to BM after transplantation, although the timing of
the homing and engraftment process is delayed.
All this supports the conclusion that, in addition
to the SDF-1-CXCR4 axis, additional redundant mecha
nisms exist. Taking all this into consideration, we
focused our investigation on the potential role of S1P.
18822
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A

B
Figure 4: A defect in long-term engraftment of WT and CXCR4−/− HSPCs in Sphk1−/− BM. Lethally irradiated Sphk1−/− mice

were transplanted with 1 × 106 BMMNCs from WT or CXCR4−/− cells. White blood cells (panel A) and platelets (panel B) were counted
at intervals (at 0, 5, 7, 11, 16, and 21 days and, for CXCR4−/− transplant, additionally at 28, 35, 42, and 49 days after transplantation). For
platelets count changes have been shown in % in comparison to day 0 for which platelet counts were assumed to be 100%. Results are
combined from two independent experiments (six mice per group, n = 12). *p < 0.05.

www.impactjournals.com/oncotarget
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there are other molecules and mechanisms involved in
homing that could compensate for an SDF-1-CXCR4
axis deficiency. For example, the involvement of Ca2+sensing mechanisms in the migration of HSPCs has been
described [31]. A similar H+-sensing mechanism could
also be involved, but this requires further study.
It is well known that SDF-1 can also bind to the
CXCR7 receptor, but the involvement of the SDF1-CXCR7 axis in the homing of HSPCs is based on
inconclusive evidence. Nevertheless, it would be
interesting to perform homing experiments in Sphk1−/−
animals with HSPCs in which both CXCR4 and
CXCR7 receptors are eliminated from the cell surface.
An alternative strategy would be to perform transplant
experiments into Sphk1−/− mice in which stromal SDF-1
is conditionally knocked out.
An important question is how conditional CXCR4
knockout BM cells engrafted in our mouse models
could be theoretically explained by an SDF-1 priming
phenomenon [32]. It is known that several soluble
factors released during conditioning for transplantation,
including elements of innate immunity, such as cleavage
fragments of C3 [33]; cationic antimicrobial peptides, such
as cathelicidin (LL-37) [34] and β2-defensin [35]; and
prostaglandin E2 (PGE2) [36], a member of the eicosanoid
family, significantly enhance responsiveness of the SDF1-CXCR4 axis. However, since CXCR4 was deleted by
~99% by Cre-recombinase in the HSPCs employed in our
experiments, SDF-1 priming effects are most likely not
involved.
In these experiments we did not address which of the
S1P receptors is most crucial for the observed phenomena,
but, based on the responsiveness of HSPCs to an S1P
gradient, the most likely candidate in S1P-mediated
homing is the S1P type 1 receptor (S1P1R) [11–16].
In conclusion, we demonstrated a defect in homing as
well as engraftment of WT HSPCs and, most importantly,
CXCR4−/− HSPCs in Sphk1−/− mice. Thus, our results
indicate that S1P expressed in the BM-microenvironment
plays a role in homing of HSPCs and supports the concept
that other chemotactic axes are involved in homing and
engraftment of HSPCs in addition to the SDF-1-CXCR4
axis (Figure 5). Further studies are needed to evaluate the
involvement of other potential homing factors, such as
C1P, extracellular nucleotides (e.g., ATP), Ca2+ sensing
mechanism, PGE2 involvement and a role of hyaluronic
acid - CD44 interaction [11, 12, 27, 31, 36, 39–42], that
may compensate for SDF-1-and S1P-mediated homing.

This phosphosphingolipid is a potent chemoattractant
for HSPCs, even more potent than SDF-1 if employed
at the physiological doses that are encountered in
biological fluids [11]. Because of its chemical structure,
S1P, in contrast to peptide-based SDF-1, is resistant, to
destruction by proteolytic enzymes, which are highly
upregulated in the BM microenvironment when it is
irradiated or conditioned by chemotherapy [10]. S1P
has been demonstrated to be involved in trafficking of
HSPCs, and, as recently demonstrated by us and others,
S1P present in PB is involved in egress of HSPCs from
BM during the mobilization process [11–16].
Interestingly, our previous research demonstrated
that mobilization of HSPCs is impaired in mice after
inhibition of S1P lyase, which degrades S1P and thus
increases its level in BM [25]. This observation, along
with the fact that S1P is upregulated after conditioning
for transplantation in the BM microenvironment [11],
prompted us to study its role in the homing process.
We report here that Sphk1−/− mice, deficient in S1P
level in BM, display impaired homing of transplanted
HSPCs. Since these mice have a normal level of
SDF-1 in BM, the lack of S1P in the hematopoietic
microenvironment was compensated after transplantation
of normal control BM cells by chemoattraction through
the SDF-1-CXCR4 axis. However, if we performed
transplants into Sphk1−/− mice employing CXCR4−/− BM
cells, we observed delayed long-term engraftment of
the transplanted cells, and this experiment revealed the
importance of the S1P homing mechanism.
However, the fact that CXCR4−/− cells were finally
able to engraft in Sphk1−/− mice suggests the existence
of other chemoattractants that are involved in this
process in addition to SDF-1 and S1P. In support of this
inference, it has been demonstrated that another bioactive
phosposphingolipid, ceramide-1-phosphate (C1P), is
also a potent chemoattractant for HSPCs [10]. We have
reported that, like the S1P level, the C1P level is also
increased in BM after myeloablative conditioning for
transplantation [10, 11]. The problem with studying the
possible involvement of C1P in the homing process is that
the receptor/s for C1P has not yet been identified, and thus
the appropriate murine knockout experimental models are
not available.
Other potential factors involved in the homing
process are extracellular nucleotides such as ATP or UTP
[26–28]. We have recently reported that the concentration
of extracellular nucleotides also increases in BM after
irradiation [29, 30]. Thus, it would be interesting to see
the effect of extracellular nucleotide receptor blockage on
homing and engraftment of HSPCs, and we are currently
planning such experiments.
Despite the fact that some crucial chemotactic
factors for HSPCs, including SDF-1, S1P, C1P, and
extracellular nucleotides (e.g., ATP and UTP), have
been identified, we cannot exclude the possibility that
www.impactjournals.com/oncotarget

MATERIAL AND METHODS
Animals
Sphk1−/− 6–8-week-old mice and age-and sex-matched
littermates, all employed in homing experiments, as well as
green immunofluorescence protein (GFP)-expressing mice
18824
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Figure 5: The proposed major mechanism underlying the processes of homing of HSPCs. HSPCs infused into blood respond
to a gradient of SDF-1 between bone marrow and blood; however, conditioning for transplantation by chemoradiotherapy may also upregulate
other homing factors, such as S1P and C1P, and increase the levels of extracellular nucleotides (ATP and UTP). Homing is also regulated by
Ca2+ gradient in the BM microenvironment. Most likely, there are also other unidentified yet factors involved in the homing process.
were purchased from The Jackson Laboratory, Bar Harbor,
ME. Cxcr4fl/fl mice (provided by Dr. Yong-Rui Zou, The
Feinstein Institute for Medical Research) were crossed
with B6.Cg-Tg(UBC-cre/ERT2)1Ejb/J mice (Jackson
Labolatory) to generate CXCR4fl/flCreTg/− mice [17]. To delete
Cxcr4, mice were injected intraperitoneally with tamoxifen
(80 mg/kg/day, Sigma-Aldrich) for five consecutive days.
The efficiency of recombination was evaluated in peripheral
blood and bone marrow after the last tamoxifen injection
and was greater than 99%. Animal studies were approved
by the Animal Care and Use Committee of the University of
Louisville (Louisville, KY).

(Sarstedt Inc., Newton, NC, USA) and run within
2 h of collection on a HemaVet 950FS hematology
analyzer (Drew Scientific Inc., Oxford, CT, USA) as
described [11].

FACS analysis
The following monoclonal antibodies were
employed to perform analytical staining of Lin−/Sca1+/c-kit+ (SKL cells) and Lin−/Sca-1+/CD45+ (HSCs):
fluorescein isothiocyanate (FITC) anti-CD117 (c-kit)
(clone2B8; BioLegend, San Diego, CA) and phycoerythrin
(PE)-Cy5 anti-mouse Ly-6A/E (Sca-1) (clone D7;
eBioscience™, San Diego, CA). All anti-mouse lineage
markers (Lin) were conjugated with PE and purchased
from BD Biosciences: anti-CD45R/B220 (clone RA36B2); anti-Ter-119 (clone TER-119); anti-CD11b (clone
M1/70); anti-T-cell receptor β (TCRβ; clone H57-597);

Peripheral blood (PB) parameter counts
To obtain leukocyte and red blood cells counts,
50 microliters of PB were taken from the retro-orbital
plexus of the mice into EDTA-coated Microvette tubes
www.impactjournals.com/oncotarget
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Evaluation of engraftment

anti-Gr-1 (clone RB6-8C5); anti-TCRγδ (clone GL3);
and anti-CD45 (clone 30-F11). All monoclonal antibodies
were added at saturating concentrations, and the cells
were then incubated for 30 min on ice, washed twice,
resuspended in RPMI-1640 plus 2% fetal bovine serum,
and analyzed with an LSR II flow cytometer (BD, San
Diego, CA, USA) [11].

For engraftment experiments, mice were irradiated
with a lethal dose of γ-irradiation (1000 cGy). After 24
h, mice were transplanted with 1.5 × 105 BM cells from
WT or Cxcr4−/− mice by tail vein injection. Femora of
transplanted mice were flushed with phosphate-buffered
saline (PBS) on day 12 post-transplant. Purified via FicollPaque, BM cells were plated in serum-free methylcellulose
cultures and stimulated to grow CFU-GM colonies with
G-CSF (25 ng/ml) plus IL-3 (10 ng/ml). After 7 days of
incubation (37°C, 95% humidity, and 5% CO2) the number
of colonies was scored under an inverted microscope.
Spleens were also removed, fixed in Telesyniczky’s
solution for CFU-S assays, and colonies were counted on
the surface of the spleen [38].

Clonogenic in vitro assay
After red blood cells (RBCs) from PB were lysed
(Pharm Lyse buffer, BD Biosciences, San Jose, CA),
the nucleated cells were subsequently washed twice
and used for CFU-GM colony formation, and cells were
counted and resuspended in human methylcellulose
base media provided by the manufacturer (R&D
Systems, Inc., Minneapolis, MN), supplemented with
25 ng/ml recombinant murine granulocyte macrophage
colony-stimulating factor (mGM-CSF) and 10 ng/ml
recombinant murine interleukin 3 (mIL-3; Millipore,
Billerica, MA). Cultures were incubated for 7 days
and then scored for the number of CFU-GM colonies
under an inverted microscope. We cultured 1 × 106
peripheral blood mononuclear cells (PBMNCs)/
dish, and final results were recalculated based on the
number of PBMNCs per 1 μl of PB. Each clonogenic
test was performed in duplicate. To evaluate the
number of clonogenic progenitor cells, bone marrow
mononuclear cells (BMMNCs) were supplemented
with erythropoietin (EPO, 5 unit/ml, Stem Cell Tech)
plus stem cell factor (SCF, 5 ng/ml), resuspended in
methylcellulose base medium for burst-forming units
(BFU-E), supplemented with thrombopoietin (TPO,
100 ng/ml) plus interleukin-3 (mIL-3, 10 ng/ml), and
resuspended in plasma cloth cultures for determining the
number of CFU-megakaryocytes (Megs) and CFU-GM
colonies, performed as above. Cultures were incubated
for 7 days (37°C, 95% humidity, and 5% CO2), at which
time they were scored under an inverted microscope for
the number of colonies, as described [11].

Recovery of leukocytes and platelets
For transplantation experiments, mice were
irradiated with a lethal dose of γ-irradiation (1000 cGy).
After 24 h, the mice were transplanted by tail vein
injection with 1 × 106 BM cells. Transplanted mice were
bled at various intervals from the retro-orbital plexus to
obtain samples for white blood cell and platelet counts as
described [37].

Chemotaxis assay
BMMNCs from WT and Cxcr4−/− mice at a density
of 1 × 106 in 100 μl were aliqoted into 5-μm polycarbonate
membrane inserts in a Costar Transwell 24-well plate (Costar
Corning, Cambridge, MA, USA) for 3 h chemotaxis at
37°C. Medium with 0.5% BSA (650 μl/well) containing
either no chemoattractant (negative control) or sphingosine1-phosphate (0.1 μM, Cayman Chemical, Michigan, USA)
was added to the lower chambers of the plate. Subsequently,
cells in the lower chambers were harvested and assayed
for the number of CFU-GM colony-forming units. Briefly,
cells were resuspended in human methylcellulose base
medium provided by the manufacturer (R&D Systems),
supplemented with GM-CSF (25 ng/ml) and IL-3 (10 ng/ml)
for determining the number of CFU-GM colonies. Cultures
were incubated for 7 days, at which time they were scored
under an inverted microscope for the number of colonies [11].

Short-term homing experiments
Mice were irradiated with a lethal dose of
γ-irradiation (1000 cGy). After 24 h, the animals were
transplanted (by tail vein injection) with 5 × 106 BM cells
from GFP mice. At 24 h after transplant, BM cells from the
femurs were isolated via Ficoll-Paque and divided. Some
cells (5 × 105) were incubated with Vybrant® DyeCycle™
Ruby stain (Invitrogen, CA) and analyzed on a flow
cytometer. The rest of the cells were plated in serum-free
methylcellulose cultures and stimulated to grow CFU-GM
colonies with granulocyte macrophage-colony stimulating
factor (GM-CSF, 25 ng/ml) and interleukin 3 (IL-3, 10
ng/ml). After 7 days of incubation (37°C, 95% humidity,
and 5% CO2) the number of colonies was scored under an
inverted microscope [37].
www.impactjournals.com/oncotarget

Statistical analysis
All results are presented as mean ± SD. Statistical
analysis of the data was done using Student’s t-test for
unpaired samples, with p ≤ 0.05 considered significant.
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